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Abstract
A major component of obesity-related insulin resistance is the establishment of a chronic inflammatory state with
invasion of white adipose tissue by mononuclear cells. This results in the release of pro-inflammatory cytokines, which
in turn leads to insulin resistance in target tissues such as skeletal muscle and liver. To determine the role of insulin
action in macrophages and monocytes in obesity-associated insulin resistance, we conditionally inactivated the insulin
receptor (IR) gene in myeloid lineage cells in mice (IR
Dmyel-mice). While these animals exhibit unaltered glucose
metabolism on a normal diet, they are protected from the development of obesity-associated insulin resistance upon
high fat feeding. Euglycemic, hyperinsulinemic clamp studies demonstrate that this results from decreased basal
hepatic glucose production and from increased insulin-stimulated glucose disposal in skeletal muscle. Furthermore,
IR
Dmyel-mice exhibit decreased concentrations of circulating tumor necrosis factor (TNF) a a n dt h u sr e d u c e dc - J u nN -
terminal kinase (JNK) activity in skeletal muscle upon high fat feeding, reflecting a dramatic reduction of the chronic
and systemic low-grade inflammatory state associated with obesity. This is paralleled by a reduced accumulation of
macrophages in white adipose tissue due to a pronounced impairment of matrix metalloproteinase (MMP) 9 expression
and activity in these cells. These data indicate that insulin action in myeloid cells plays an unexpected, critical role in
the regulation of macrophage invasion into white adipose tissue and in the development of obesity-associated insulin
resistance.
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Introduction
Obesity in humans and rodents is associated with increased
expression of pro-inflammatory cytokines, such as tumor necrosis
factor (TNF) a, in white adipose tissue (WAT) [1–4]. This results
from increased cytokine expression in WAT and more importantly
from infiltration of WAT by macrophages [5–7]. Elevated
concentrations of these cytokines activate the c-Jun N-terminal
kinase (JNK)-, nuclear factor (NF) kB- and Jak/Stat/Socs-signaling
pathways in metabolic target tissues of insulin action such as
skeletal muscle and liver, thereby inhibiting insulin signal
transduction [8–10]. Inactivation of the inhibitor of NFkB kinase
beta (IKK2), the main activator of TNF-a-stimulated NFkB
activation in myeloid cells, protects mice from the development of
obesity-associated insulin resistance [11]. These findings suggest
that macrophages play a key role in the development of obesity-
associated insulin resistance and type 2 diabetes. More recently, a
critical role in the development of obesity-associated inflammation
has also been demonstrated for mast cells and lymphocytes
[12,13].
Early studies indicated that macrophages and monocytes
express insulin receptors [14], however, the physiological function
of these receptors has been a matter of debate. Macrophages and
monocytes have been shown to respond to insulin with increased
phagocytosis and glucose metabolism [15] and with increased
TNF-a production and inhibition of apoptosis [16,17]. Addition-
ally, it has been reported that bone marrow-specific deletion of
cbl-associated protein (CAP), a downstream molecule of the insulin
signaling cascade, protects mice against obesity-induced insulin
resistance [18]. To directly address the role of insulin action and
resistance in myeloid cells, we generated mice with cell type-
specific deletion of the insulin receptor in this lineage (IR
Dmyel-
mice). We have previously reported that these animals, upon
exposure to a high cholesterol diet, exhibit protection from the
development of atherosclerosis in the presence of reduced
inflammation on an apolipoprotein E (ApoE)-deficient background
PLoS Genetics | www.plosgenetics.org 1 May 2010 | Volume 6 | Issue 5 | e1000938[19]. However, others reported more complex lesions in the
absence of myeloid cell insulin action through activation of the
endoplasmatic reticulum (ER) stress pathway on a low-density
lipoprotein receptor (LDLR)-deficient background [20]. Nonethe-
less, these studies did not address the role of insulin action and
insulin resistance in myeloid lineage cells under conditions of
obesity and obesity-induced inflammation and insulin resistance.
To analyze the impact of myeloid cell-restricted insulin resistance
on the development of systemic insulin resistance associated with
obesity, we characterized glucose metabolism in control- and
IR
Dmyel-mice receiving either a normal chow diet or a high fat
diet.
Results
Myeloid cell-restricted insulin resistance does not affect
obesity development upon high fat feeding
As previously shown, crossing IR
flox/flox-mice with mice
expressing the Cre-recombinase under control of the lysozymeM
promoter resulted in efficient, myeloid cell-restricted ablation of
the insulin receptor [19] (Figure 1A and 1B). Under normal chow
diet (NCD), control- and IR
Dmyel-mice exhibited indistinguishable
weight curves, white adipose tissue mass, body fat content, serum
leptin concentrations and serum free fatty acids (FFA) (Figure 1C–
1G). When exposed to high fat diet (HFD), control-mice
significantly gained weight over animals exposed to NCD, and
the degree of weight gain was similar between control- and
IR
Dmyel-mice (Figure 1C). Moreover, white adipose tissue mass,
body fat content, circulating leptin concentrations as an indirect
measure of fat mass and serum FFA were significantly elevated in
mice exposed to HFD, but indistinguishable between control- and
IR
Dmyel-mice (Figure 1D–1G). Additionally, food intake, oxygen
(O2) consumption and respiratory exchange ratio (RER) were
modulated by exposure to HFD but did not show any difference
between both genotypes (Figure 1H–1J). Taken together, these
results indicate that insulin receptors on myeloid cells are not
required for energy homeostasis under NCD and HFD feeding
and that myeloid cell-restricted insulin resistance does not affect
the development of obesity upon high fat feeding.
IR
Dmyel-mice exhibit improved glucose metabolism upon
high fat feeding
To address the role of myeloid cell insulin action on whole body
glucose metabolism, we next determined blood glucose and serum
insulin concentrations in control- and IR
Dmyel-mice. Both
parameters were indistinguishable between genotypes under
NCD (Figure 2A and 2B). As expected, on HFD, control-mice
developed significantly increased blood glucose and serum insulin
concentrations suggestive of insulin resistance (Figure 2A and 2B).
Glucose and insulin levels did also rise in obese IR
Dmyel-mice, but
strikingly, this increase was significantly blunted in these mice
lacking insulin receptors in myeloid cells (Figure 2A and 2B).
Consistent with this, glucose tolerance was similar in control-
and IR
Dmyel-mice under NCD and became impaired in control-
mice administered a HFD (Figure 2C). In contrast, IR
Dmyel-mice
receiving the HFD demonstrated only a minimal impairment in
glucose tolerance compared to control- or IR
Dmyel-mice on NCD
(Figure 2C). Similarly, obese IR
Dmyel-mice showed significantly
higher insulin sensitivity as measured by insulin tolerance test
when compared to HFD-fed control-mice, whereas insulin
sensitivity was comparable between both groups under NCD
(Figure 2D). Taken together, these data reveal that myeloid cell-
restricted insulin receptor deficiency leads to striking protection
from obesity-induced insulin resistance.
IR
Dmyel-mice exhibit reduced hepatic glucose production
and improved insulin action in skeletal muscle upon high
fat feeding
To further define in which tissues myeloid cell-autonomous
insulin resistance affects systemic glucose metabolism on HFD, we
performed euglycemic, hyperinsulinemic clamps in control- and
IR
Dmyel-mice after 12 weeks of exposure to HFD. This analysis
revealed a significant decrease in basal hepatic glucose production
in IR
Dmyel- compared to control-mice, while insulin-suppressed
HPG (steady state) was similar in both groups (Figure 2E).
Accordingly, obese IR
Dmyel-mice exhibited a 50% reduction in the
hepatic expression of a key enzyme of gluconeogenesis, glucose-6-
phosphatase (G6Pase), while expression of phosphoenolpyruvate
carboxykinase (Pck1) remained unchanged (Figure 2F).
In addition, insulin-stimulated glucose disposal in skeletal muscle
was significantly increased in IR
Dmyel- compared to control-mice,
whereas insulin-stimulated glucose uptake in brain and adipose
tissue remained unaltered under clamp conditions (Figure 2G).
In summary, these experiments indicate that the major
improvement in glucose metabolism of obese IR
Dmyel-mice results
from both increased insulin sensitivity in skeletal muscle and
reduced basal hepatic glucose production.
Decreased systemic, obesity-associated inflammatory
response in IR
Dmyel-mice
As insulin resistance in response to obesity and high fat feeding
has been demonstrated to arise from increased concentrations of
local and circulating pro-inflammatory cytokines [21] and from a
reduction of circulating adiponectin concentrations [22,23], we
determined these parameters in control- and IR
Dmyel-mice.
Exposure of control-mice to HFD induced a marked increase of
serum TNF-a concentrations compared to animals fed NCD.
Strikingly, this obesity-induced increase in TNF-a was completely
blunted in IR
Dmyel-mice (Figure 3A). Moreover, while high fat
feeding significantly reduced the portion of high molecular weight
(HMW) adiponectin of total serum adiponectin in control animals,
this diet-induced reduction was not observed in IR
Dmyel-mice
(Figure 3B).
Author Summary
Obesity represents a major health burden with steadily
increasing incidence. While it is associated with numerous
co-morbidities, type 2 diabetes mellitus represents one of
the major life-threatening, obesity-related conditions. Over
the last years, it has become clear that during the course of
obesity development not only does fat mass increase, but
also fat composition changes qualitatively, leading to an
influx of inflammatory cells, such as macrophages, into
adipose tissue. Macrophages in turn secrete inflammatory
mediators, which inhibit insulin action in skeletal muscle,
liver, and even the central nervous system to ultimately
cause insulin-resistant diabetes mellitus. However, the
effect of insulin action and resistance in these inflamma-
tory cell types themselves has not been addressed. To this
end, we have generated and analyzed mice with
inactivation of the insulin receptor specifically in myeloid
cell-derived, inflammatory cells. Surprisingly, these animals
are protected from the development of obesity-associated
deterioration of glucose metabolism, thereby defining
insulin action in inflammatory cells as a novel and
promising target for therapeutic intervention against
obesity-associated diabetes mellitus.
Macrophage IR-Knockout
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Dmyel-mice exhibit unaltered response to normal chow and high fat diet. (A) Western blot analysis of insulin receptor (IR) b and
Akt (loading control) expression in thioglycollate-elicited macrophages of control- and IR
Dmyel-mice. (B) Western blot analysis of IR-b and Akt (loading
control) in brain, liver, skeletal muscle (SM) and white adipose tissue (WAT) of control- and IR
Dmyel-mice. (C) Weight curves of male control- and
IR
Dmyel-mice fed NCD or HFD. (n=12 mice per genotype on NCD; n=32 mice per genotype on HFD.) (D) Epididymal fat pad mass of male control- and
IR
Dmyel-mice fed either NCD or HFD. (n=15 mice per genotype and diet.) (E) Body fat content of male control- and IR
Dmyel-mice fed either NCD or
HFD. (n=4–10 mice per genotype and diet.) (F) Serum leptin concentrations of male control- and IR
Dmyel-mice fed either NCD or HFD. (n=6–16 mice
per genotype and diet.) (G) Serum free fatty acid (FFA) concentrations of male control- and IR
Dmyel-mice fed either NCD or HFD. (n=10–12 mice per
genotype and diet.) (H) Daily food intake of male control- and IR
Dmyel-mice fed either NCD or HFD. (n=4–10 mice per genotype and diet.) (I) Oxygen
(O2) consumption of male control- and IR
Dmyel-mice fed either NCD or HFD. (n=4–10 mice per genotype and diet.) (J) Respiratory exchange ratio
(RER) of male control- and IR
Dmyel-mice fed either NCD or HFD. (n=4–10 mice per genotype and diet.) (Results are means 6 SEM; white bars represent
controls and black bars represent IR
Dmyel-mice).
doi:10.1371/journal.pgen.1000938.g001
Macrophage IR-Knockout
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strated to activate inflammatory signaling cascades critical in the
development of insulin resistance in classical insulin target tissues,
we next directly investigated the activation of c-Jun N-terminal
kinase (JNK) signaling in liver and skeletal muscle of obese control
and IR
Dmyel-mice. This analysis revealed, that basal JNK activity,
as assessed by phosphorylation of c-Jun, was significantly reduced
in skeletal muscle and exhibited a trend towards reduction in liver
of obese IR
Dmyel-mice compared to controls (Figure 3C and 3D).
Furthermore, expression of pro-inflammatory cytokines TNF-a
and IL-6 was reduced in skeletal muscle, but not liver of obese
IR
Dmyel-mice (Figure 3E). However, the number of macrophages,
which represent a major source for these cytokines, was unaltered
in either tissue as demonstrated by similar expression of the
macrophage-specific mRNA F4/80 in both groups of mice
(Figure 3E).
Taken together, these experiments demonstrate that myeloid
cell-restricted insulin resistance protects from obesity-associated
systemic changes in the circulating concentrations of cytokines and
adipokines as well as the local activation of JNK in skeletal muscle.
Decreased macrophage recruitment and obesity-
associated inflammation in white adipose tissue of
IR
Dmyel-mice
To address whether the observed reduction in systemic, obesity-
associated inflammatory response correlates with alterations of the
local, obesity-associated infiltration of adipose tissue by macro-
phages, we next analyzed the expression of F4/80, a specific
marker for this cell-type, in WAT of control- and IR
Dmyel-mice by
quantitative realtime PCR analysis. Compared to NCD, high fat
feeding significantly enhanced expression of F4/80 mRNA in
Figure 2. IR
Dmyel-mice are protected against obesity-induced insulin resistance. (A) Fasted blood glucose concentrations of male control-
and IR
Dmyel-mice fed either NCD or HFD. (n=6–7 mice per genotype on NCD; n=33–36 mice per genotype on HFD.) (B) Fasted serum insulin
concentrations of male control- and IR
Dmyel-mice fed either NCD or HFD. (n=6–7 mice per genotype on NCD; n=10 mice per genotype on HFD.) (C)
Glucose Tolerance Tests were performed with male control- and IR
Dmyel-mice fed NCD or HFD. (n=6–13 mice per genotype and diet.) (D) Insulin
Tolerance Tests were performed with male control- and IR
Dmyel-mice fed NCD or HFD. (n=4–11 mice per genotype and diet.) (E) Hepatic glucose
production (HGP) of male, HFD-fed control- and IR
Dmyel-mice before (basal) and during (steady state) euglycemic, hyperinsulinemic clamp analysis.
(n=12 mice per genotype.) (F) Relative expression of G6Pase and Pck1 mRNA in livers of fasted control- and IR
Dmyel-mice fed HFD (n=6 mice per
genotype.) (G) Tissue-specific glucose uptake rate (GUR) of male, HFD-fed control- and IR
Dmyel-mice under steady state conditions. (WAT=white
adipose tissue; SM=skeletal muscle; n=10 mice per genotype.) (Results are means 6 SEM; white bars represent controls and black bars represent
IR
Dmyel-mice; *p#0.05; **p#0.01; ***p#0.001.)
doi:10.1371/journal.pgen.1000938.g002
Macrophage IR-Knockout
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increase of this marker was almost completely abolished in WAT
of IR
Dmyel-mice (Figure 4A). This decrease appeared to represent
reduced macrophage recruitment, since bone marrow-derived
macrophages (BMDM) of IR
Dmyel-mice showed unaltered expres-
sion of F4/80 mRNA under basal conditions and after treatment
with the saturated fatty acid palmitate compared to control cells
(Figure S1A). Importantly, among classical insulin target tissues,
only adipose tissue showed drastically increased diet-induced
expression of F4/80 mRNA, while expression in obese liver and
skeletal muscle was not significantly modulated in wildtype
animals compared to NCD (Figure S1B).
Furthermore, we performed histological analyses of WAT
obtained from obese control- and IR
Dmyel-mice. No difference
was observable in adipocyte morphology or adipocyte size
distribution between control- and IR
Dmyel-mice on high fat diet
(Figure 4B and 4C), consistent with unaltered obesity development
in these animals. However, in line with the reduced mRNA
expression of macrophage marker genes, immunohistochemical
analysis of infiltrating, activated macrophages demonstrated a
striking reduction of Mac-2-positive cells in WAT of diet-induced
obese IR
Dmyel-mice compared to control-mice (Figure 4D and 4E).
Thus, the reduced F4/80 mRNA and Mac-2 antigen expression in
WAT in the presence of unaltered macrophage-autonomous
marker gene expression clearly provides independent experimental
evidence for reduced macrophage recruitment to WAT of
IR
Dmyel-mice upon high fat feeding.
Since not only macrophages, but also a variety of other immune
cells are highly abundant in the obese adipose tissue and
contribute to the development of obesity-induced insulin resistance
[12,13,24], we assessed mRNA expression of different immune cell
markers in the stromal vascular (SV) fraction of WAT from obese
control- and IR
Dmyel-mice. In control mice, markers for macro-
phages (F4/80), dendritic cells (CD11c), granulocytes (Gr-1), T-
lymphocytes (CD3, CD4, CD8) and mast cells (Kit) were highly
enriched in the SV fraction compared to adipocytes (Figure 5A).
However, in line with the data on whole WAT, we observed a
specific reduction of the macrophage marker F4/80, but not of
markers for granulocytes, mast cells, dendritic cells or T-
lymphocytes, in the SV fraction of IR
Dmyel-mice (Figure 5A).
Consistent with the specific reduction of macrophage infiltra-
tion, further analysis revealed a decrease in mRNA expression of
the cytokine TNF-a and the chemokine CCL3/MIP-1a in SV
fraction of IR
Dmyel-mice (Figure 5B), indicating reduced inflam-
mation in this compartment. Notably, although TNF-a, interleu-
kin (IL) 1b, interferon (IFN) c and arginase (Arg) 1 showed higher
expression in SV fraction than in adipocytes, IL-6, CCL2/MCP-1,
CCL5/Rantes and CXCL5 were equally if not higher expressed
by adipocytes compared to SV fraction (Figure 5B).
To verify efficient separation of adipocytes from SV fraction, we
analyzed expression of leptin, adiponectin and CD34 in both
compartments. As expected, leptin and adiponectin were exclu-
sively expressed in adipocytes, while CD34 expression was highly
restricted to the SV fraction (Figure 5C).
Figure 3. The obesity-associated systemic pro-inflammatory state is reduced in IR
Dmyel-mice. (A) Serum TNF-a concentration in male
control- and IR
Dmyel-mice fed either NCD or HFD. (n=12 mice per genotype on NCD; n=21 mice per genotype on HFD.) (B) Percentage of serum high
molecular weight (HMW) from total adiponectin in male control- and IR
Dmyel-mice fed either NCD or HFD. (n=10–12 mice per genotype and diet.) (C)
In vitro phosphorylation of c-Jun (p-c-Jun) in skeletal muscle (SM) and liver lysates from male, HFD-fed control- and IR
Dmyel-mice. Total JNK input was
used as loading control. (representative western blot shown). (D) Densitometrical analysis of phospho-c-Jun vs total JNK. (AU=arbitrary units;
SM=skeletal muscle; n=6 mice per genotype.) (E) Relative expression of F4/80, TNF-a and IL-6 mRNA in skeletal muscle (SM) and liver of male, HFD-
fed control- and IR
Dmyel-mice. (n=6 mice per genotype.) (Results are means 6 SEM; white bars represent controls and black bars represent IR
Dmyel-
mice; *p#0.05; **p#0.01; n.s.=not significant.)
doi:10.1371/journal.pgen.1000938.g003
Macrophage IR-Knockout
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in adipocytes from IR
Dmyel-mice compared to controls, pointing
towards increased insulin sensitivity in these animals (Figure 5C).
Taken together, our data indicate that disruption of the insulin
receptor in myeloid cells specifically interferes with the obesity-
associated recruitment of macrophages to adipose tissue and
ultimately leads to reduced local expression of cytokines and
chemokines in WAT.
Insulin receptor–deficient macrophages exhibit increased
susceptibility to lipid-induced apoptosis and reduced
expression of matrix metalloproteinase 9
The observed reduction of adipose tissue macrophage content in
obese IR
Dmyel-mice, among other factors, might arise from (i) enhanced
susceptibility to apoptosis or (ii) reduced invasive capacity of these cells.
To directly address the hypothesis that IR signaling in
macrophages might control these processes, we first analyzed the
regulation of apoptosis in response to fatty acids to mimic the
metabolic environment present upon high fat feeding. To this end,
macrophages were isolated from the bone marrow of control- and
IR
Dmyel-mice, stimulated with palmitate in the absence or presence
of insulin and TUNEL assays were performed. Palmitate
stimulation profoundly induced apoptosis in control macrophages
and insulin significantly reduced the number of TUNEL-positive
cells in control cells both in the absence and presence of lipid
stimulation (Figure S2A, S2B). However, insulin failed to reduce
apoptosis in the IR-deficient macrophages in either the basal or
palmitate-stimulated state (Figure S2A, S2B). Furthermore,
quantitative realtime PCR analysis suggested that the protective
effect of insulin is mediated through stimulation of Bcl-2 mRNA
rather than suppression of Bax mRNA expression (Figure S2C,
S2D). Nonetheless, this in vitro observation did neither translate
into increased numbers of apoptotic macrophages in adipose tissue
nor into reduced numbers of circulating monocytes in obese
IR
Dmyel-mice (data not shown).
Besides control of macrophage survival, an important prereq-
uisite for macrophage invasion into tissues is their ability to express
Figure 4. The obesity-associated macrophage infiltration into white adipose tissue is blunted in IR
Dmyel-mice. (A) Relative expression of
F4/80 mRNA in WAT of male control- and IR
Dmyel-mice fed either NCD or HFD. (n=8 mice per genotype and diet.) (B) Hematoxylin and eosin staining
of white adipose tissue (WAT) sections from male control- and IR
Dmyel-mice fed HFD. (C) Adipocyte size distribution in WAT of male control- and
IR
Dmyel-mice fed HFD. (n=9 mice per genotype.) (D) Mac-2 staining of WAT-sections from male control- and IR
Dmyel-mice fed HFD; Red arrows indicate
Mac-2 positive area surrounding the adipocytes. (E) Percentage of Mac-2 positive area per section in male control- and IR
Dmyel-mice fed HFD. (n=9
mice per genotype.) (Results are means 6 SEM; white bars represent controls and black bars represent IR
Dmyel-mice; *p#0.05; scale bars=200 mm.)
doi:10.1371/journal.pgen.1000938.g004
Macrophage IR-Knockout
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degrade extracellular matrix (ECM) proteins to allow trans-ECM
migration. Since it has recently been established that MMP-9
(gelatinase B) plays a critical role in inflammatory macrophage
migration [25], we assessed MMP-9 expression and activation in
macrophages of control- and IR
Dmyel-mice. Peritoneally elicited
macrophages were either left untreated (basal) or were stimulated
with palmitate and expression of MMP-9 mRNA was determined.
Intriguingly, IR-deficient cells exhibited a dramatic reduction of
MMP-9 mRNA expression both in the basal state as well as upon
stimulation with palmitate (Figure 6A). Importantly, IR disruption
in macrophages not only affected MMP-9 expression, but also
translated into reduced MMP-9 activity. Thus, zymographical
analysis of conditioned media revealed higher MMP-9 activity in
those obtained from control macrophages compared to those from
IR-deficient cells (Figure 6B).
To verify the in vivo relevance of this cell-autonomous impairment
in MMP-9 expression and activation, we first determined serum
MMP-9 concentrations in lean and obese controland IR
Dmyel-mice.
While HFD induced a highly significant increase of circulating
MMP-9 in control animals, this increase was less profound in
IR
Dmyel-mice (Figure 6C). Furthermore, we assessed gelatinolytic
activity in WAT lysates of obese control- and IR
Dmyel-mice.
Strikingly, while MMP-2 activation was unaltered, WAT of
IR
Dmyel-mice exhibited drastically reduced MMP-9 activation
compared to controls, possibly reflecting the reduced accumulation
of macrophages in this compartment (Figure 6D and 6E).
To further functionally analyze the effect of IR-deficiency on
macrophage migration, we performed transwell migration assays
with wildtype BMDM transfected with siRNAs directed against
either IR or MMP-9. Compared to a scrambled control siRNA,
both oligonucleotides mediated efficient and specific knockdown of
their respective target mRNAs without reducing expression of
closely related insulin-like growth factor (IGF) 1 receptor and
MMP-2 mRNA (Figure 6F). BMDM transfected with the control
siRNA showed an approximately 4-fold increase of migrated cells
through gelatin-coated membranes in response to MCP-1
compared to the basal level (Figure 6G). However, knockdown
of MMP-9 significantly blunted this response and MCP-1 failed to
enhance basal migration significantly (Figure 6G). Strikingly,
siRNA-mediated ablation of IR reduced macrophage migration
capacity to a similar degree as that of MMP-9 (Figure 6G).
Taken together, our experiments reveal that insulin action in
macrophages promotes tissue invasion capacity of these cells in vitro
and in vivo, thereby critically controlling high fat diet-associated
macrophage invasion and activation in WAT upon induction of
obesity.
Discussion
Insulin resistance in metabolically relevant insulin target tissues,
such as skeletal muscle, liver, adipose tissue and more recently the
brain, represents a well-studied key characteristic during the
development of type 2 diabetes mellitus [26–30]. Insulin resistance
can arise via different mechanisms e.g. mutations in genes
encoding insulin signaling components or their reduced expression
[31,32]. However, it has been demonstrated that insulin resistance
associated with obesity largely stems from posttranslational
Figure 5. Obese IR
Dmyel-mice exhibit reduced macrophage marker and pro-inflammatory gene expression in stromal vascular cells
of the adipose tissue. (A) Relative expression of immune cell markers F4/80, CD11c, Gr-1, CD3, CD4, CD8 and Kit mRNA in adipocytes (A) and
stromal vascular (SV) fraction of male control- and IR
Dmyel-mice fed HFD. (n=5 mice per genotype.) (B) Relative expression of cytokines and
chemokines TNF-a, IL-6, IL-1b, IFNc, Arg1, CCL2/MCP1, CCL3/MIP1a, CCL5/Rantes and CXCL5 mRNA in adipocytes (A) and stromal vascular (SV)
fraction of male control- and IR
Dmyel-mice fed HFD. (n=5 mice per genotype.) (C) Relative mRNA expression of adipocyte-specific genes leptin and
adiponectin (adipoq) and stromal vascular cell-specific gene CD34 in adipocytes (A) and stromal vascular (SV) fraction of male control- and IR
Dmyel-
mice fed HFD. (n=5 mice per genotype.) (Results are means 6 SEM; white bars represent controls and black bars represent IR
Dmyel-mice; *p#0.05;
***p#0.001.)
doi:10.1371/journal.pgen.1000938.g005
Macrophage IR-Knockout
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phosphorylation of the insulin receptor or its downstream signaling
mediators [33]. Here, activation of pro-inflammatory signaling
cascades, particularly JNK and IKK, have been shown to inhibit
insulin action, although to different, tissue-specific extent [8,34–36].
The establishment of a chronic pro-inflammatory state during the
course of obesity stems from expression of pro-inflammatory
cytokines in adipose tissue, particularly through the recruitment of
cells of the innate immune response system to WAT [5,7]. The
critical importance of innate immune response activation during the
development of obesity-associated insulin resistance has been
highlighted by the phenotype of mice with targeted disruption of
the NFkB pathway in myeloid lineage cells, as well as mice deficient
for the chemokine receptor CCR2, which both exhibit reduced
WAT inflammation and are therefore protected from obesity-
induced insulin resistance [11,37].
While these findings have provided compelling evidence for the
immune response pathway to cause insulin resistance in liver,
skeletal muscle and adipose tissue, the primary effect of insulin
action and insulin resistance in cells of the innate immune system
has been poorly investigated and remains controversial. Thus,
while there is considerable evidence for a role of inflammation in
producing insulin resistance in individuals with type 2 diabetes
[38–40], it has also been shown that insulin treatment of obese
humans can reverse the pro-inflammatory state in macrophages
[41,42], raising a question of which is cause and which is effect.
Also, it is not clear if this anti-inflammatory effect is a direct effect
of insulin on cells of the immune system or if the reversal of
inflammation occurs secondary to normalization of hyperglycemia
and other metabolic abnormalities [43]. To further complicate the
matter, insulin has been shown to directly increase TNF-a
expression in human monocytes, pointing towards a possible
Figure 6. Myeloid cell-restricted insulin receptor deficiency leads to reduced matrix metalloproteinase (MMP) 9 expression in
macrophages and white adipose tissue of IR
Dmyel-mice. (A) Relative expression of MMP-9 mRNA in peritoneal macrophages of control- and
IR
Dmyel-mice. Cells were left untreated (basal) or stimulated with palmitate (500 mM) for 4 h. (n=3 independent experiments.) (B) Conditioned
medium from 24 h untreated (basal) and insulin-stimulated (50 ng/ml) bone marrow-derived macrophages (BMDM) of control- and IR
Dmyel-mice (IR
2/2) was analyzed for MMP-9 gelatinolytic activtity. (representative zymogram of 3 independent experiments shown.) (C) Serum MMP-9
concentration in male control- and IR
Dmyel-mice fed either NCD or HFD. (n=10–12 mice per genotype and diet.) (D) White adipose tissue lysates from
obese control- and IR
Dmyel-mice were analyzed for gelatinolytic activity. (E) Densitometrical analysis of MMP-9 vs MMP-2 in zymograms of WAT from
obese control- and IR
Dmyel-mice. (AU=arbitrary units; n=3.) (F) Relative expression of insulin receptor (IR), insulin-like growth factor 1 receptor (Igf1r),
matrix metalloproteinase (MMP) 9 and MMP-2 mRNA in silenced BMDM. (white bars=siRNA Ctrl, black bars=siRNA IR, grey bars=siRNA MMP-9;
n=3.) (G) Chemotaxis of silenced BMDM through a gelatin matrix was analyzed using a transwell migration assay. (white bars=basal migration, black
bars=migration against 100 ng/ml MCP-1; n=3 independent experiments.) (Results are means 6 SEM; white bars represent controls and black bars
represent IR-deficient macrophages/IR
Dmyel-mice unless stated otherwise; *p#0.05; ***p#0.001; n.s.=not significant.)
doi:10.1371/journal.pgen.1000938.g006
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Indeed, the latter is consistent with our previous observation that
myeloid cell-restricted insulin resistance protects apolipoproteinE-
deficient mice from the development of atherosclerosis due to
impaired inflammatory response [19]. Alternatively, differential
pro- and anti-inflammatory effects of insulin may represent
different stages of a process representing acute versus chronic
stimulation [44].
The findings of the present study directly demonstrate an
unexpected and pivotal role for insulin signal transduction in the
control of innate immune cell behavior in the obese state, such that
chronic impairment of insulin action in myeloid lineage cells
protects from obesity-associated inflammation. This is further
supportedbytheobservationthatmicewithbonemarrow-restricted
disruption of cbl-associated protein (CAP), a downstream compo-
nent of insulin action in control of glucose transport, are protected
from obesity-associated inflammation and insulin resistance [18].
However, these experiments did not specifically address the role of
insulinaction, as CAP is a scaffold proteinimplicatedboth in insulin
signaling and also cytoskeleton regulation [45,46].
The present results not only reveal clearly that IR-dependent
signaling is critical for macrophage recruitment to WAT upon
obesity development, they also define at least two potential
mechanisms responsible for this phenomenon: increased apoptosis
of macrophages and reduced tissue invasion by these cells due to
decreased expression of MMP-9.
It is well documented that insulin can protect macrophages
from apoptosis induced by numerous stimuli, such as serum/
glucose deprivation, lipopolysaccharides and UV-irradiation in
vitro [17,20,47]. More recently, Senokuchi et al. showed that insulin
protects macrophages from ER stress-mediated apoptosis by free
cholesterol in the development of atherosclerosis [20,48]. Consis-
tent with the latter notion, we find that saturated fatty acids, such
as palmitate, which are increased in the circulation of obese
patients [49], can result in macrophage apoptosis and that this
effect is inhibited by insulin in vitro. However, we could not observe
increased macrophage apoptosis in adipose tissue or altered
numbers of circulating monocytes in obese IR
Dmyel-mice, ques-
tioning the in vivo relevance of this finding.
Aside from regulation of macrophage apoptosis, we find that
insulin promotes expression and activation of MMP-9 in these
cells, a protease involved in tissue invasion by macrophages [25].
Furthermore, we could directly demonstrate that siRNA-mediated
ablation of MMP-9 drastically impairs macrophage transmigration
through a gelatin matrix and that this can be phenocopied by loss
of the insulin receptor. Consistent with these results, it has been
demonstrated that insulin augments MMP-9 in human monocytes
in vitro [50] and that degradation of extracellular matrix (ECM)
components by MMP-9 represents a key step during macrophage
tissue invasion [51]. Indeed, reduced MMP-9 activity diminishes
macrophage trans-ECM migration and protects from local
inflammation and inflammation-associated cardiovascular disease
[25]. Interestingly, San Jose ´ et al. have recently demonstrated that
insulin activates MMP-9 in murine macrophages in a PI3K/PKC-
dependent manner through stimulation of the NADPH oxidase
system [52]. Here, the authors propose that insulin-dependent
MMP-9 activation might contribute to plaque instability in
atherosclerotic lesions. Taking that into account, our results
underline the important role of insulin receptor-dependent
regulation of MMP-9 in macrophages and further extend it to
another hyperinsulinemia-related disease state i.e. the develop-
ment of obesity-associated inflammation and insulin resistance.
Notably, the LysMCre transgene mediates recombination of
loxP-flanked alleles not only in macrophages but also in other
myeloid lineage-derived cell types [53]. Therefore, one key
question remains why, in our model, the reduction of adipose
tissue infiltration is specific for macrophages while marker
expression of other immune cell types e.g. granulocytes, T-
lymphocytes and mast cells was unchanged. This might be due to
the time-dependent fashion in which different subsets of immune
cells invade the adipose tissue over the course of obesity. While
adipose tissue granulocytes and T-lymphocytes already appear
after 7 days and 6 weeks, respectively [13,24], macrophage
numbers do not significantly increase before 12–16 weeks of high
fat feeding [7,13]. Therefore, we cannot exclude that, despite
macrophages, adipose tissue numbers of distinct immune cell
subsets may be changed at different stages of obesity in our model.
Additionally, immune cells invading the adipose tissue, especially
macrophages and T-lymphocytes, can be further divided into
distinct subtypes which are characterized by differential expression
of specific surface markers [13,54,55]. Thus, analysis of adipose
tissue immune cell populations by fluorescence activated cell
sorting (FACS) could potentially yield a higher resolution of
adipose tissue inflammatory cell composition than the quantitative
realtime PCR analysis performed in this study. Nevertheless, our
experiments indicate that protection from diet-induced insulin
resistance appears to be primarily paralleled by reduced WAT-
macrophage recruitment.
Another question is why reduced macrophage accumulation in
obese IR
Dmyel-mice is restricted to adipose tissue, while no
significant difference of F4/80 expression could be observed in
liver and skeletal muscle of these animals. This might be explained
by our finding that in wildtype mice the obesity-induced
infiltration of macrophages into adipose tissue is several magni-
tudes higher (,20-fold vs NCD) than into liver and skeletal muscle
(max. 2-fold). Therefore, the effect of general macrophage-
autonomous impairment of migration ability may be particularly
predominant in adipose tissue compared to other insulin target
tissues.
In conclusion, our study directly demonstrates that, despite its
positive effects on glucose metabolism in target tissues such as liver,
skeletal muscle and WAT, in vivo insulin can also play a deleterious
role during the development of the metabolic syndrome by its
actions in cells of the innate immune response system. The
molecular mechanism of how the insulin receptor signaling
pathway affects macrophage function remains to be further
defined, but the present study suggests that this may offer a site
for pharmacological intervention that could lead to novel
therapeutic strategies for metabolic diseases.
Methods
Animals
All animal procedures were conducted in compliance with
protocols approved by local government authorities and were in
accordance with NIH guidelines. Mice were housed in groups of
3–5 at 22–24uC in a 12:12 h light/dark cycle with lights on at 6
a.m. Animals were either fed a normal chow diet (Teklad Global
Rodent # T.2018.R12; Harlan, Germany) containing 53.5% of
carbohydrates, 18.5% of protein, and 5.5% of fat (12% of calories
from fat) or from week 4 of age a high fat diet (# C1057; Altromin,
Germany) containing 32.7%, 20% and 35.5% of carbohydrates,
protein and fat (55.2% of calories from fat), respectively. Water
was available ad libitum and food was only withdrawn if required
for an experiment. Body weight was measured once a week.
Genomic DNA was isolated from tail tips, genotyping was
performed by PCR. All experiments on mice were performed at
16 weeks of age.
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LysMCre mice were mated with IR
lox/lox mice, and a breeding
colony was maintained by mating IR
lox/lox with LysMCre-IR
lox/lox
mice. IR
lox mice had been backcrossed for at least 5 generations on
a C57BL/6 background, and LysMCre mice – initially established
on a C57BL6/129sv background – had been backcrossed for 10
generations on a C57BL6 background before intercrossing them
with IR
lox mice. Only male animals from the same mixed
background strain generation were compared to each other.
LysMCre mice were genotyped by PCR as previously described
[53]. IR
lox/lox mice were genotyped by PCR with primers crossing
the loxP site as previously described [26].
Body composition
Body fat content was measured in vivo by nuclear magnetic
resonance using a minispec mq7.5 (Bruker Optik, Ettlingen,
Germany) as previously described [56].
Indirect calorimetry and food intake
All measurements were performed in a PhenoMaster System
(TSE systems, Bad Homburg, Germany), which allows measure-
ment of metabolic performance. Mice were placed at room
temperature (22uC–24uC) in 7.1-l chambers of the PhenoMaster
open circuit calorimetry. Mice were allowed to adapt to the
chambers for at least 24h. Food and water were provided ad libitum
in the appropriate devices and measured by the build-in
automated instruments. Parameters of indirect calorimetry and
food intake were measured for at least the following 48 hr.
Presented data are average values obtained in these recordings.
Glucose and insulin tolerance tests
Glucose tolerance tests were performed after a 16–17h fasting
period. After determination of fasted blood glucose levels, each
animal received an i.p. injection of 20% glucose (10ml/kg)
(DeltaSelect, Germany). Blood Glucose levels were detected after
15, 30, 60 and 120 minutes. Insulin tolerance tests were performed
with mice fed ad libitum. After determination of basal blood glucose
levels, each animal obtained an i.p. injection of insulin, 0.75U/kg
(Actrapid; Novo Nordisk A/S, Denmark), and blood glucose was
measured 15, 30 and 60 minutes after insulin injection.
Euglycemic, hyperinsulinemic clamp studies
Catheter implantation. At the age of 16 weeks, male mice
were anesthetized by intraperitoneal injection of avertin and
adequacy of the anesthesia was ensured by the loss of pedal
reflexes. A Micro-Renathane catheter (MRE 025; Braintree
Scientific Inc., MA, USA) was inserted into the right internal
jugular vein, advanced to the level of the superior vena cava, and
secured in its position in the proximal part of the vein with 4-0 silk;
the distal part of the vein was occluded with 4-0 silk. After
irrigation with physiological saline solution, the catheter was filled
with heparin solution and sealed at its distal end. The catheter was
subcutaneously tunneled, thereby forming a subcutaneous loop,
and exteriorized at the back of the neck. Cutaneous incisions were
closed with a 3-0 silk suture and the free end of the catheter was
attached to the suture in the neck as to permit the retrieval of the
catheter on the day of the experiment. Mice were intraperitoneally
injected with 1 ml of saline containing 15mg/g body weight of
tramadol and placed on a heating pad in order to facilitate
recovery.
Clamp experiment. Only mice that had regained at least
90% of their preoperative body weight after 6 days of recovery
were included in the experimental groups. After starvation for
15 hours, awake animals were placed in restrainers for the
duration of the clamp experiment. After a D-[3-
3H]Glucose
(Amersham Biosciences, UK) tracer solution bolus infusion (5mCi),
the tracer was infused continuously (0.05mCi/min) for the duration
of the experiment. At the end of the 40-minute basal period, a
blood sample (50ml) was collected for determination of the basal
parameters. To minimize blood loss, red blood cells were collected
by centrifugation and reinfused after being resuspended in saline.
Insulin (human regular insulin; NovoNordisc Pharmaceuticals,
Inc., NJ, USA) solution containing 0.1% BSA (Sigma-Aldrich,
Germany) was infused at a fixed rate (4mU/g/min) following a
bolus infusion (40mU/g). Blood glucose levels were determined
every 10 minutes (B-Glucose Analyzer; Hemocue AB, Sweden)
and physiological blood glucose levels (between 120 and 150 mg/
dl) were maintained by adjusting a 20% glucose infusion
(DeltaSelect, Germany). Approximately 60 minutes before steady
state was achieved, a bolus of 2-Deoxy-D-[1-
14C]Glucose (10mCi,
Amersham) was infused. Steady state was ascertained when
glucose measurements were constant for at least 30 min at a
fixed glucose infusion rate and was achieved within 100 to
130 min. During the clamp experiment, blood samples (5ml) were
collected after the infusion of the 2-Deoxy-D-[1-
14C]Glucose at
the time points 0, 5, 15, 25, 35 min etc. until reaching the steady
state. During the steady state, blood samples (50ml) for the
measurement of steady state parameters were collected. At the end
of the experiment, mice were killed by cervical dislocation, and
brain, WAT and skeletal muscle tissues were dissected and stored
at 220uC. Assays. Plasma [3-
3H]Glucose radioactivity of basal
and steady state samples was determined directly after
deproteinization with 0.3M Ba(OH)2 and 0.3M ZnSO4 and also
after removal of
3H2O by evaporation, using a liquid scintillation
counter (Beckmann, Germany). Plasma Deoxy-[1-
14C]Glucose
radioactivity was directly measured in the liquid scintillation
counter. Tissue lysates were processed through Ion exchange
chromatography columns (Poly-Prep
R Prefilled Chromatography
Columns, AG
R1-X8 formate resin, 200–400 mesh dry; Bio Rad
Laboratories, CA, USA) to separate 2-Deoxy-D-[1-
14C]Glucose
(2DG) from 2-Deoxy-D-[1-
14C]Glucose-6-Phosphate (2DG6P).
Calculations. Glucose turnover rate (mg6kg
216min
21) was
calculated as the rate of tracer infusion (dpm/min) divided by the
plasma glucose-specific activity (dpm/mg) corrected for body
weight. HGP (mg6kg
216min
21) was calculated as the difference
between the rate of glucose appearance and glucose infusion rate.
In vivo glucose uptake for each tissue (nmol6g
216min
21) was
calculated based on the accumulation of 2DG6P in the respective
tissue and the disappearance rate of 2DG from plasma as
described previously [57].
Isolation of murine macrophages
Peritoneal macrophages. Mice were injected intreaperi-
toneally with 2 ml thioglycollate medium (4% in PBS). On day 4
post injection, the animals were sacrificed by CO2 anesthesia and
cells were collected by peritoneal lavage with sterile PBS. After
several washing steps, cells were resuspended in RPMI 1640
(supplemented with 10% FCS, 1% glutamine, 1% penicillin-
streptomycin) and plated at a density of 10
6 cells/ml.
Bone marrow–derived macrophages. Mice were sacrificed
by CO2 anesthesia, rinsed in 70% (v/v) ethanol and bone marrow
was isolated from femurs and tibias. After several washing steps,
bone marrow cells were resuspended in IMDM (supplemented
with 10% FCS, 1% glutamine, 1% penicillin-streptomycin and
10 ng/ml recombinant M-CSF (Peprotech)). Bone marrow cells
were plated at a concentration of 1–2610
6 cells/ml in IMDM
(supplemented with 10% FCS, 1% glutamine, 1% penicillin-
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bacterial petridishes and differentiated for 7–10 days. Preceding
all the experiments, macrophages were washed two times with
sterile PBS and, if stimulated with insulin, serum-starved for 16–
20 h. Palmitate media was prepared as previously described [58].
siRNA transfections
650 pmole siRNA (Silencer Select siRNA negative control,
#4390846; Insr, #S68367; MMP9, #S69944; Applied Biosys-
tems, CA, USA) were transferred to a 4-mm cuvette (Bridge,
Providence, RI) and incubated for 3 minutes with 4610
6
bone marrow-derived macrophages (BMDM) in 100 mL Optimem
(Invitrogen, Frederick, MD) before electroporation in a
Gene Pulser X cell + CE module (Bio-Rad, Hercules, CA). Pulse
conditions were square wave, 1000 V, 2 pulses, and 0.5-ms pulse
length. 72–96 hours after electroporation, RNAi efficiency was
tested using quantitative realtime PCR and silenced BMDM were
used for functional assays.
Analytical procedures
Blood glucose levels were determined from whole venous blood
usinganautomaticglucosemonitor (GlucoMen GlycO ´ ;A.Menarini
Diagnostics, Italy). Leptin, insulin, TNF-a, adiponectin and MMP-9
levels in serum were measured by ELISA using mouse standards
according to manufacturer’s guidelines (Mouse Leptin ELISA;
Crystal Chem, IL, USA / Mouse Insulin ELISA; Crystal Chem, IL,
USA / Mouse Adiponectin (HMW & total) ELISA; Alpco, NH,
USA / Mouse TNF-a/TNFSF1A and MMP-9 (total) Quantikine
ELISA Kit; R&D Systems, Inc., MN, USA). Serum FFAs were
determined by colorimetric assay according to manufacturer’s
guidelines (NEFA kit; Wako chemicals GmbH, Neuss, Germany).
Western blot analysis
Protein isolation from cells and tissues was performed as
previously described [26]. Western blot analysis was performed as
previously described [26] with antibodies raised against insulin
receptor b subunit (IRb, catalog # sc-711; Santa Cruz
Biotechnology Inc.) and Akt (catalog # 9272; Cell Signaling) as
a loading control. SAPK/JNK Kinase assay (catalog # 9810; Cell
Signaling Technology Inc.) was performed following the manu-
facturers instructions. Western blot analysis of total JNK input was
performed with an antibody raised against JNK (catalog # 9252;
Cell Signaling Technology Inc.). Quantification of changes in
optical density was performed with Quantity One (Bio-Rad
Laboratories, Mu ¨nchen, Germany).
Gelatin zymography
Gelatin zymography was performed as previously described [59].
Briefly, cell culture supernatants and tissue extracts were purified
from lower molecular weight proteins (,50 kDa) by centrifugation
through Microcon YM-50 Centrifugal Filter Units (Millipore,
Billerica, MA, USA). 10–40 mg of protein were separated on SDS
polyacrylamide gels (containing 0.1 mg/ml gelatine). Gels were
renatured in 2.5% Triton X-100 followed by incubation in MMP
activation buffer (50 mM Tris-HCl, 5 mM CaCl2,p H8 )a t3 7 uC
overnight in a humidified chamber. Gels were stained with 2.5 g/l
Coomassie brilliant-blue R-250. Destaining was carried out with
40% (v/v) methanol until the bands appeared clearly.
Isolation of adipocytes and stromal vascular fraction
Animals were sacrificed and epididymal fat pads were removed
under sterile conditions. Adipocytes were isolated by collagenase
(1 mg/ml) digestion for 45 min at 37uC in DMEM/Ham’s F-12 1:1
(DMEM/F12) containing 1% BSA. Digested tissues were filtered
through sterile 150-mm nylon mesh and centrifuged at 2506gf o r
5 min. The floating fraction consisting of pure isolated adipocytes
was then removed and washed three more times before proceeding
toexperiments.Thepellet,representing thestromalvascularfraction
containing preadipocytes, macrophages and other cell types, was
resuspended in erythrocyte lysis buffer consisting of 154 mM
NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA for 10 min.
Analysis of gene expression
RNA was isolated from cells and tissues using the Qiagen
RNeasy Kit (Qiagen, Germany). The RNA was reversely
transcribed with EuroScript Reverse Transcriptase (Eurogentec,
Belgium) and amplified using TaqMan Universal PCR-Master
Mix, NO AmpErase UNG with TaqMan Assay-on-demand kits
(Applied Biosystems, CA, USA). Relative expression of target
mRNAs (Adiponectin Mm00456425_m1, Arg1 Mm00475988_
m1, Bcl2 Mm00477631_m1, Bax Mm00432050_m1, Ccl2
Mm00441242_m1, Ccl3 Mm00441258, Ccl5 Mm01302428_m1,
Cxcl5 Mm00436451_g1, CD11c Mm00498698_m1, CD3
Mm00442746_m1, CD34 Mm00519283_m1, CD4 Mm00442754_
m1, CD8 Mm01182108_m1, F4/80 Mm00802530_m1, G6pase
Mm839363_m1, Gr-1 Mm00459644_m1, Il1b Mm00434228_
m1, Il6 Mm00446190_m1, Ifng Mm00801778_m1, Igf1r
Mm00802841_m1, InsR Mm00439693_m1, Kit Mm00445212_
m1, Leptin Mm00434759, Mmp2 Mm00439506_m1, Mmp9
Mm00442991_m1, Pck1 Mm00440636_m1, TNFa Mm00443258_
m1) was determined using standard curves based on WAT and
samples were adjusted for total mRNA content by hypoxanthine
guanine phosphoribosyl transferase 1 (Hprt1 Mm00446968_m1)
mRNA quantitative PCR. Calculations were performed by a
comparative method (2
2DDCT). Quantitative PCR was performed
on an ABI-PRISM 7900 HT Sequence Detector (Applied
Biosystems, Germany). Assays were linear over 4 orders of
magnitude.
Apoptosis assay
For assessment of apoptosis in primary macrophages, the
DeadEnd
TM Fluorometric TUNEL system (Promega Corpora-
tion, Madison, WI, USA) was used. The protocol for adherent cells
was carried out according to the manufacturer’s instructions.
Slides were mounted with Vectashield DAPI medium (Vector
Laboratories Inc, Burlingame, CA, USA) and analyzed under a
fluorescence microscope. Quantification of DAPI- and FITC-
positive cells was performed using AxioVision 4.2 (Carl Zeiss
MicroImaging GmbH, Oberkochen, Germany).
Transwell migration assay
Chemotaxis of BMDM was quantified using transwell migration
assays. Polycarbonate filters (Costar, Corning, 24-well, 8 mm pore
size) were coated with gelatin (0.2%, Sigma) for 1h at room
temperature or overnight at 4uC. BMDM (2610
5 cells in 300 ml
IMDM/0,5% FCS) were placed in the upper compartment and
subsequently incubated at 37uC/5% CO2 to adhere. After 1h,
100 ng/ml MCP-1 (Peprotech) was added to IMDM/0,5% FCS
in the lower compartment. Control assays were performed without
chemokine. After incubation for 4 h at 37uC/5% CO2, transmi-
grated cells were stained with DAPI and nuclei were counted
under a fluorescence microscope.
Immunohistochemistry
Immunohistochemistry was performed on paraffin sections as
previously described [60]. Quantification of adipocyte size and
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Zeiss MicroImaging GmbH, Oberkochen, Germany).
Statistical methods
Data was analyzed for statistical significance using a two-tailed
unpaired student’s T-Test.
Supporting Information
Figure S1 (A) Relative expression of F4/80 mRNA in untreated
(basal) and palmitate (500 mM) stimulated bone marrow-derived
macrophages of control- and IR
Dmyel-mice. (n=4 independent
experiments; white bars represent control and black bars IR-
deficient macrophages.) (B) Relative expression of F4/80 mRNA
in liver and skeletal muscle (SM) of male C57Bl/6 mice fed either
NCD or HFD for 22 weeks. (n=8; white bars represent NCD and
black bars HFD-fed animals.) (Results are means 6 SEM;
n.s.=not significant.)
Found at: doi:10.1371/journal.pgen.1000938.s001 (0.17 MB
TIF)
Figure S2 Insulin receptor-deficient macrophages are prone to
lipid-induced apoptosis. (A) TUNEL assay of bone marrow-
derived macrophages of control- and IR
Dmyel-mice (IR
2/2)
(representative pictures shown). Cells were left untreated (basal)
or treated with insulin (50 ng/ml), palmitate (500 mM) or both for
24 h. (B) The percentage of TUNEL-positive cells (green) of the
number of DAPI-positive nuclei (blue) was determined micro-
scopically. (n=4.) (C) Relative expression of Bax mRNA in bone
marrow-derived macrophages of control- and IR
Dmyel-mice. Cells
were left untreated (basal) or treated with insulin (50 ng/ml),
palmitate (500 mM) or both for 8 h. (n=4.) (D) Relative expression
of Bcl-2 mRNA in bone marrow-derived macrophages of control-
and IR
Dmyel-mice. Cells were left untreated (basal) or treated with
insulin (50 ng/ml), palmitate (500 mM) or both for 8 h. (n=4.)
(Results are means 6 SEM; white bars represent control and black
bars represent IR-deficient macrophages *p#0.05; **p#0.01;
***p#0.001; n.s.=not significant.)
Found at: doi:10.1371/journal.pgen.1000938.s002 (2.47 MB
TIF)
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